Related Experiment Video
Updated: Sep 30, 2025

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
Acute idiopathic maculopathy after COVID-19 vaccination
Taiji Hasegawa1, Yoka Sannomiya2, Momoka Toyoda1
1Department of Ophthalmology, Tokyo Women's Medical University, Tokyo, Japan.
Purpose:
We report a case of acute idiopathic maculopathy (AIM) that developed after COVID-19 vaccination.
Observations:
A 54-year-old woman complained of a sudden decrease of visual acuity in her right eye one day after receiving a second COVID-19 vaccination (Pfizer). Fundus photograph showed a circular yellow lesion at the fovea in right eye. Optical coherence tomography revealed the thickening of retinal pigment epithelium and the presence of subretinal fluid. Three months after the initial visit, the BCVA and the fundus images had favorable recovery in the right eye.
Conclusions And Importance:
We describe a case of AIM after receiving COVID-19 vaccination. These findings may be a helpful in understanding the pathogenesis of AIM.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Photoreceptors and Visual Pathways

